Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)—results from the ILUVIT study

被引:0
|
作者
Svenja K. Deuchler
Ralf Schubert
Pankaj Singh
Adonis Chedid
Ninel Kenikstul
Julia Scott
Thomas Kohnen
Hanns Ackermann
Frank Koch
机构
[1] Augenzentrum Frankfurt,Department of Ophthalmology
[2] Goethe University Hospital,Pneumological
[3] Goethe University Hospital,Immunological Laboratory
[4] Goethe University Hospital,Institute of Biostatistics
关键词
Cytokines; Diabetic macular edema; Diabetic retinopathy; Fluocinolone acetonide; Growth factors; Inflammatory markers;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2537 / 2547
页数:10
相关论文
共 50 条
  • [1] Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)-results from the ILUVIT study
    Deuchler, Svenja K.
    Schubert, Ralf
    Singh, Pankaj
    Chedid, Adonis
    Kenikstul, Ninel
    Scott, Julia
    Kohnen, Thomas
    Ackermann, Hanns
    Koch, Frank
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (08) : 2537 - 2547
  • [2] Reduced vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (FAc, ILUVIEN) implant in patients with persistent or recurrent DME - results from the ILUVIT study
    Deuchler, Svenja
    Singh, Pankaj
    Chedid, Adonis
    Brui, Natallia
    Kohnen, Thomas
    Ackermann, Hanns
    Koch, Frank H. J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [3] Real-Life Results after the Administration of a Single 0.19 mg Fluocinolone Acetonide (ILUVIEN®) Implant in Patients with Refractory Diabetic Macular Edema
    Darwisch, Warda
    della Volpe-Waizel, Maria
    Roberts, Philipp K.
    Boden, Karl T.
    Szurman, Peter
    Rickmann, Annekatrin
    OPHTHALMIC RESEARCH, 2024, 67 (01) : 600 - 610
  • [4] Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
    Yahiya Y. Syed
    Drugs, 2017, 77 : 575 - 583
  • [5] Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
    Syed, Yahiya Y.
    DRUGS, 2017, 77 (05) : 575 - 583
  • [6] Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    William Fusi-Rubiano
    Rebecca R. Blow
    Mark Lane
    Rupal Morjaria
    Alastair K. Denniston
    Ophthalmology and Therapy, 2018, 7 : 293 - 305
  • [7] Iluvien (Fluocinolone Acetonide 0.19mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    Fusi-Rubiano, William
    Blow, Rebecca R.
    Lane, Mark
    Morjaria, Rupal
    Denniston, Alastair K.
    OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) : 293 - 305
  • [8] Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    William Fusi-Rubiano
    Rebecca R. Blow
    Mark Lane
    Rupal Morjaria
    Alastair K. Denniston
    Ophthalmology and Therapy, 2020, 9 : 205 - 205
  • [9] Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN® (0.19 mg fluocinolone acetonide implant)
    Augustin, Albert J.
    Bopp, Silvia
    Fechner, Martin
    Holz, Frank
    Sandner, Dirk
    Winkgen, Andrea-M
    Khoramnia, Ramin
    Neuhann, Thomas
    Warscher, Marcus
    Spitzer, Martin
    Sekundo, Walter
    Seitz, Berthold
    Duncker, Tobias
    Ksinsik, Christian
    Hoeh, Helmuth
    Gentsch, Daniela
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (02) : 382 - 391
  • [10] RETINAL THICKNESS RESULTS PRIOR AND FOLLOWING TREATMENT WITH 0.19 MG FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR DIABETIC MACULAR EDEMA
    Carneiro, Angela M.
    Meireles, Angelina
    Sousa, Joao
    Teixeira, Carla
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)